An Inhalable Medicament Comprising Tiotropium

Patent No. EP2793886 (titled "An Inhalable Medicament Comprising Tiotropium") was filed by Teva Pharmaceuticals on Dec 6, 2012. The application was issued on Aug 24, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
3M UNITED KINGDOM PLCMay 24, 2017VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2793886

TEVA PHARMACEUTICALS
Application Number
EP12806382A
Filing Date
Dec 6, 2012
Status
Revoked
Sep 10, 2021
Publication Date
Aug 24, 2016